Over the past few years, several hot investing trends swept through Wall Street. First, it was the metaverse, and now it's artificial intelligence; there will likely be some new big thing in a year or two. But one industry that remains consistently attractive to invest in is healthcare. That should remain the case through the next decade -- and likely much longer -- unless someone invents an all-purpose cure for all diseases.

Assuming that won't happen, let's consider two healthcare stocks worth buying and hanging onto for the next 10 years: Abbott Laboratories (NYSE: ABT) and Intuitive Surgical (NASDAQ: ISRG).

Abbott Laboratories has a deep and diversified presence in healthcare, especially in its medical-devices area of expertise. The company's results have been somewhat volatile in recent years due to its diagnostics segment, which has seen its revenue fluctuate based on COVID-19 cases. Abbott markets several coronavirus diagnostic products. In the first quarter, the company's revenue of about $10 billion declined by 11.4% year over year for this reason.

Continue reading

Source Fool.com